e7 peptide enhances the adhesion and migration ability of cells

e7 peptide YMLDLQPET is a linear peptidic epitope - ole-henriksen-peptide-boost E7-LP35 is an optimal tumor antigen

ole-henriksen-moisturizer-peptide The e7 peptide refers to a specific protein fragment derived from the E7 oncoprotein of the Human Papillomavirus (HPV)Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ .... This peptide is of significant interest in scientific research, particularly in the development of HPV therapeutic vaccines and in understanding the mechanisms of viral oncogenesis.Human Papillomavirus (HPV) E7 protein (49-57) - 1 mg The E7 oncoprotein itself plays a crucial role in viral genome replication and cellular transformation by binding to and degrading tumor suppressor proteins like the retinoblastoma protein (pRb). Consequently, e7 peptide sequences are often studied for their ability to elicit immune responses and potentially target HPV-associated cancers.

Understanding the E7 Peptide in HPV

Human Papillomaviruses (HPVs), especially high-risk types like HPV16 and HPV18, encode early proteins E6 and E7. These oncoproteins are fundamental to the virus's ability to cause cellular changes that can lead to cancer.The Human Papillomavirus E7 Oncoprotein Functionally Interacts ... The E7 protein, in particular, is known to interact with key cellular regulators of the cell cycle, driving uncontrolled cell proliferation. Researchers utilize specific e7 peptide sequences, such as those derived from HPV16, to investigate these interactions and to develop immunotherapies. These peptides can act as antigens for stimulating T-cell responses, which are critical for controlling viral infections and eliminating cancerous cellsDevelopment and evaluation of a novel E7 multi-epitopic ....

Applications in Therapeutic Vaccines and Research

The e7 peptide is a focal point in the field of cancer immunotherapyHuman Papillomavirus (HPV) E7 protein(49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope (short peptide spanning the 49th to 57th amino .... By isolating specific epitopes from the E7 oncoprotein, scientists aim to create targeted vaccines. For instance, the HPV16 E7 peptide, often in various forms like pools of peptides or specific sequences such as RAHYNIVTF, is used in research to stimulate antigen-specific T cells. These T-cell assays are vital for evaluating the immunogenicity of potential vaccine candidates.Protein E7 - an overview Furthermore, research explores how these peptides can be conjugated to nanoparticles or combined with adjuvants to enhance their effectiveness as tumor antigens, aiming to induce robust cell-mediated immune responses against HPV-driven malignancies.

E7 Peptide Variations and Research Focus

The scientific literature highlights numerous specific e7 peptide sequences, often defined by their amino acid range within the E7 protein and their restriction to particular human leukocyte antigen (HLA) types, such as HLA-A2 or H-2Db作者:O Trejo Cerro·2023—In this work, using a smallHPV16 E7 peptidein a proteomic approach, we report Memo1 as a new E7 binding partner, interacting through the aspartic and glutamic .... These variations are critical because the immunogenicity of a peptide is heavily influenced by its ability to bind to MHC molecules and be presented to T cells. Studies investigate E7 peptides for their role in viral genome replication and their potential to enhance cell adhesion and migration, suggesting broader biological functions beyond oncogenesis. The development of peptide pools, like the PepTivator HPV16 E7, allows for a comprehensive study of immune responses against various E7 epitopes.

Challenges and Future Directions

Despite the promise, developing effective e7 peptide-based therapies faces challenges. The complexity of the immune system and the variability of HPV strains require careful selection and optimization of peptide sequencesHuman Papillomavirus Oncoprotein E7-C (HPV- .... Research continues to explore optimal peptide lengths, combinations, and delivery methods to maximize therapeutic efficacyHPV 16 E7 peptide RAHYNIVTF (H-2 Db) is a single peptide for stimulation of T cells. The peptide from human papillomavirus type 16 (HPV16) protein E8 is .... The goal is to create vaccines that can effectively prevent and treat HPV-associated cancers by eliciting potent and durable immune responses directed against the E7 oncoprotein. The ongoing study of E7 peptides is thus central to advancing our understanding of HPV pathogenesis and developing novel treatment strategies.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.